TW389791B - Assaying nucleotides in solution using pna probes - Google Patents

Assaying nucleotides in solution using pna probes Download PDF

Info

Publication number: TW389791B
Authority: TW; Taiwan
Prior art keywords: probe; patent application; nucleotide sequence; scope; intensity
Prior art date: 1997-02-27

Application number

TW087102841A

Other languages

English (en)

Chinese (zh)

Inventor

Eileen Xiao-Feng Nie

Yung-Min Wu

Original Assignee

Lorne Park Res Usa Llc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-02-27

Filing date

1998-03-12

Publication date

2000-05-11

1997-06-06 Priority claimed from US08/870,370 external-priority patent/US6060242A/en

1998-03-12 Application filed by Lorne Park Res Usa Llc filed Critical Lorne Park Res Usa Llc

2000-05-11 Application granted granted Critical

2000-05-11 Publication of TW389791B publication Critical patent/TW389791B/zh

Links

239000000523 sample Substances 0.000 title claims abstract description 409
239000002773 nucleotide Substances 0.000 title claims abstract description 121
125000003729 nucleotide group Chemical group 0.000 title claims abstract description 119
238000000034 method Methods 0.000 claims abstract description 121
238000009396 hybridization Methods 0.000 claims abstract description 47
239000007788 liquid Substances 0.000 claims abstract description 32
239000007787 solid Substances 0.000 claims abstract description 14
108020004414 DNA Proteins 0.000 claims description 181
239000012634 fragment Substances 0.000 claims description 55
230000000295 complement effect Effects 0.000 claims description 45
239000002609 medium Substances 0.000 claims description 39
230000002079 cooperative effect Effects 0.000 claims description 32
238000005259 measurement Methods 0.000 claims description 21
238000012360 testing method Methods 0.000 claims description 19
239000001963 growth medium Substances 0.000 claims description 16
238000009630 liquid culture Methods 0.000 claims description 16
239000000203 mixture Substances 0.000 claims description 16
238000011049 filling Methods 0.000 claims description 14
239000007850 fluorescent dye Substances 0.000 claims description 14
239000013642 negative control Substances 0.000 claims description 14
150000007523 nucleic acids Chemical group 0.000 claims description 14
102000053602 DNA Human genes 0.000 claims description 13
238000001514 detection method Methods 0.000 claims description 12
239000003550 marker Substances 0.000 claims description 12
239000002777 nucleoside Substances 0.000 claims description 11
238000000926 separation method Methods 0.000 claims description 11
108091028043 Nucleic acid sequence Proteins 0.000 claims description 9
239000002253 acid Substances 0.000 claims description 8
230000005855 radiation Effects 0.000 claims description 8
150000003833 nucleoside derivatives Chemical class 0.000 claims description 7
150000003839 salts Chemical class 0.000 claims description 7
239000013641 positive control Substances 0.000 claims description 6
238000005119 centrifugation Methods 0.000 claims description 5
239000000084 colloidal system Substances 0.000 claims description 5
230000005684 electric field Effects 0.000 claims description 5
GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 claims description 5
-1 argon ion Chemical class 0.000 claims description 4
150000001875 compounds Chemical class 0.000 claims description 4
238000004925 denaturation Methods 0.000 claims description 4
230000036425 denaturation Effects 0.000 claims description 4
238000001962 electrophoresis Methods 0.000 claims description 4
238000001914 filtration Methods 0.000 claims description 4
230000001678 irradiating effect Effects 0.000 claims description 4
PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 claims description 4
238000009434 installation Methods 0.000 claims description 3
238000001556 precipitation Methods 0.000 claims description 3
XKRFYHLGVUSROY-UHFFFAOYSA-N argon Substances [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 claims description 2
229910052786 argon Inorganic materials 0.000 claims description 2
238000005406 washing Methods 0.000 claims description 2
238000012544 monitoring process Methods 0.000 claims 6
PCTMTFRHKVHKIS-BMFZQQSSSA-N (1s,3r,4e,6e,8e,10e,12e,14e,16e,18s,19r,20r,21s,25r,27r,30r,31r,33s,35r,37s,38r)-3-[(2r,3s,4s,5s,6r)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-19,25,27,30,31,33,35,37-octahydroxy-18,20,21-trimethyl-23-oxo-22,39-dioxabicyclo[33.3.1]nonatriaconta-4,6,8,10 Chemical compound C1C=C2C[C@@H](OS(O)(=O)=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2.O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 PCTMTFRHKVHKIS-BMFZQQSSSA-N 0.000 claims 2
229910052778 Plutonium Inorganic materials 0.000 claims 2
OYEHPCDNVJXUIW-UHFFFAOYSA-N plutonium atom Chemical compound [Pu] OYEHPCDNVJXUIW-UHFFFAOYSA-N 0.000 claims 2
235000015170 shellfish Nutrition 0.000 claims 2
102000040350 B family Human genes 0.000 claims 1
108091072128 B family Proteins 0.000 claims 1
BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims 1
230000015572 biosynthetic process Effects 0.000 claims 1
239000013522 chelant Substances 0.000 claims 1
238000004898 kneading Methods 0.000 claims 1
OXNIZHLAWKMVMX-UHFFFAOYSA-N picric acid Chemical group OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-N 0.000 claims 1
238000010791 quenching Methods 0.000 claims 1
230000000171 quenching effect Effects 0.000 claims 1
239000013643 reference control Substances 0.000 claims 1
229910052709 silver Inorganic materials 0.000 claims 1
239000004332 silver Substances 0.000 claims 1
238000012163 sequencing technique Methods 0.000 abstract 1
238000002189 fluorescence spectrum Methods 0.000 description 67
239000000243 solution Substances 0.000 description 66
239000000872 buffer Substances 0.000 description 17
OSBLTNPMIGYQGY-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetic acid;boric acid Chemical compound OB(O)O.OCC(N)(CO)CO.OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O OSBLTNPMIGYQGY-UHFFFAOYSA-N 0.000 description 15
239000008051 TBE buffer Substances 0.000 description 15
230000035772 mutation Effects 0.000 description 14
102000039446 nucleic acids Human genes 0.000 description 12
108020004707 nucleic acids Proteins 0.000 description 12
125000003275 alpha amino acid group Chemical group 0.000 description 10
108090000623 proteins and genes Proteins 0.000 description 10
238000001228 spectrum Methods 0.000 description 9
IGXWBGJHJZYPQS-SSDOTTSWSA-N D-Luciferin Chemical compound OC(=O)[C@H]1CSC(C=2SC3=CC=C(O)C=C3N=2)=N1 IGXWBGJHJZYPQS-SSDOTTSWSA-N 0.000 description 8
CYCGRDQQIOGCKX-UHFFFAOYSA-N Dehydro-luciferin Natural products OC(=O)C1=CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 CYCGRDQQIOGCKX-UHFFFAOYSA-N 0.000 description 8
BJGNCJDXODQBOB-UHFFFAOYSA-N Fivefly Luciferin Natural products OC(=O)C1CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 BJGNCJDXODQBOB-UHFFFAOYSA-N 0.000 description 8
DDWFXDSYGUXRAY-UHFFFAOYSA-N Luciferin Natural products CCc1c(C)c(CC2NC(=O)C(=C2C=C)C)[nH]c1Cc3[nH]c4C(=C5/NC(CC(=O)O)C(C)C5CC(=O)O)CC(=O)c4c3C DDWFXDSYGUXRAY-UHFFFAOYSA-N 0.000 description 8
239000000975 dye Substances 0.000 description 7
230000005284 excitation Effects 0.000 description 6
239000003446 ligand Substances 0.000 description 6
239000000126 substance Substances 0.000 description 6
108091093037 Peptide nucleic acid Proteins 0.000 description 5
YIWGJFPJRAEKMK-UHFFFAOYSA-N 1-(2H-benzotriazol-5-yl)-3-methyl-8-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carbonyl]-1,3,8-triazaspiro[4.5]decane-2,4-dione Chemical compound CN1C(=O)N(c2ccc3n[nH]nc3c2)C2(CCN(CC2)C(=O)c2cnc(NCc3cccc(OC(F)(F)F)c3)nc2)C1=O YIWGJFPJRAEKMK-UHFFFAOYSA-N 0.000 description 4
108020004682 Single-Stranded DNA Proteins 0.000 description 4
238000004458 analytical method Methods 0.000 description 4
239000007853 buffer solution Substances 0.000 description 4
OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 4
230000000694 effects Effects 0.000 description 4
108090000765 processed proteins & peptides Proteins 0.000 description 4
102000004169 proteins and genes Human genes 0.000 description 4
238000000746 purification Methods 0.000 description 4
230000000717 retained effect Effects 0.000 description 4
RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 4
NIPNSKYNPDTRPC-UHFFFAOYSA-N N-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 NIPNSKYNPDTRPC-UHFFFAOYSA-N 0.000 description 3
108091034117 Oligonucleotide Proteins 0.000 description 3
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
239000003153 chemical reaction reagent Substances 0.000 description 3
238000007796 conventional method Methods 0.000 description 3
238000005516 engineering process Methods 0.000 description 3
YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 2
PTDZLXBJOJLWKG-UHFFFAOYSA-N 5-(bromomethyl)-1h-pyrimidine-2,4-dione Chemical compound BrCC1=CNC(=O)NC1=O PTDZLXBJOJLWKG-UHFFFAOYSA-N 0.000 description 2
GVUOPSNMFBICMM-UHFFFAOYSA-N 5-bromo-6-morpholin-4-yl-1h-pyrimidine-2,4-dione Chemical compound OC1=NC(O)=C(Br)C(N2CCOCC2)=N1 GVUOPSNMFBICMM-UHFFFAOYSA-N 0.000 description 2
GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 2
229930024421 Adenine Natural products 0.000 description 2
108091003079 Bovine Serum Albumin Proteins 0.000 description 2
102000014914 Carrier Proteins Human genes 0.000 description 2
108020004635 Complementary DNA Proteins 0.000 description 2
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
102000004190 Enzymes Human genes 0.000 description 2
108090000790 Enzymes Proteins 0.000 description 2
AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 2
PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
239000004952 Polyamide Substances 0.000 description 2
241000218206 Ranunculus Species 0.000 description 2
238000002105 Southern blotting Methods 0.000 description 2
JAWMENYCRQKKJY-UHFFFAOYSA-N [3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-ylmethyl)-1-oxa-2,8-diazaspiro[4.5]dec-2-en-8-yl]-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]methanone Chemical compound N1N=NC=2CN(CCC=21)CC1=NOC2(C1)CCN(CC2)C(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F JAWMENYCRQKKJY-UHFFFAOYSA-N 0.000 description 2
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 2
229960000643 adenine Drugs 0.000 description 2
108091008324 binding proteins Proteins 0.000 description 2
229910052797 bismuth Inorganic materials 0.000 description 2
JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical compound [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 description 2
229940098773 bovine serum albumin Drugs 0.000 description 2
239000003795 chemical substances by application Substances 0.000 description 2
229940104302 cytosine Drugs 0.000 description 2
238000007405 data analysis Methods 0.000 description 2
230000007423 decrease Effects 0.000 description 2
238000013461 design Methods 0.000 description 2
201000010099 disease Diseases 0.000 description 2
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
210000002950 fibroblast Anatomy 0.000 description 2
238000001917 fluorescence detection Methods 0.000 description 2
238000002509 fluorescent in situ hybridization Methods 0.000 description 2
239000000499 gel Substances 0.000 description 2
239000011521 glass Substances 0.000 description 2
239000001257 hydrogen Substances 0.000 description 2
229910052739 hydrogen Inorganic materials 0.000 description 2
150000002500 ions Chemical class 0.000 description 2
239000002184 metal Substances 0.000 description 2
229910052751 metal Inorganic materials 0.000 description 2
230000003278 mimic effect Effects 0.000 description 2
125000003835 nucleoside group Chemical group 0.000 description 2
RZJRJXONCZWCBN-UHFFFAOYSA-N octadecane Chemical compound CCCCCCCCCCCCCCCCCC RZJRJXONCZWCBN-UHFFFAOYSA-N 0.000 description 2
238000012856 packing Methods 0.000 description 2
229920002647 polyamide Polymers 0.000 description 2
229920000768 polyamine Polymers 0.000 description 2
102000040430 polynucleotide Human genes 0.000 description 2
108091033319 polynucleotide Proteins 0.000 description 2
239000002157 polynucleotide Substances 0.000 description 2
ZCCUUQDIBDJBTK-UHFFFAOYSA-N psoralen Chemical compound C1=C2OC(=O)C=CC2=CC2=C1OC=C2 ZCCUUQDIBDJBTK-UHFFFAOYSA-N 0.000 description 2
239000006228 supernatant Substances 0.000 description 2
ZEMGGZBWXRYJHK-UHFFFAOYSA-N thiouracil Chemical compound O=C1C=CNC(=S)N1 ZEMGGZBWXRYJHK-UHFFFAOYSA-N 0.000 description 2
229950000329 thiouracil Drugs 0.000 description 2
229940113082 thymine Drugs 0.000 description 2
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
JEOQACOXAOEPLX-WCCKRBBISA-N (2s)-2-amino-5-(diaminomethylideneamino)pentanoic acid;1,3-thiazolidine-4-carboxylic acid Chemical compound OC(=O)C1CSCN1.OC(=O)[C@@H](N)CCCN=C(N)N JEOQACOXAOEPLX-WCCKRBBISA-N 0.000 description 1
125000002861 (C1-C4) alkanoyl group Chemical group 0.000 description 1
NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 1
SNBCLPGEMZEWLU-QXFUBDJGSA-N 2-chloro-n-[[(2r,3s,5r)-3-hydroxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methyl]acetamide Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CNC(=O)CCl)[C@@H](O)C1 SNBCLPGEMZEWLU-QXFUBDJGSA-N 0.000 description 1
VXGRJERITKFWPL-UHFFFAOYSA-N 4',5'-Dihydropsoralen Natural products C1=C2OC(=O)C=CC2=CC2=C1OCC2 VXGRJERITKFWPL-UHFFFAOYSA-N 0.000 description 1
LLIANSAISVOLHR-GBCQHVBFSA-N 5-[(3as,4s,6ar)-2-oxidanylidene-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoic acid Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21.N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 LLIANSAISVOLHR-GBCQHVBFSA-N 0.000 description 1
102000007469 Actins Human genes 0.000 description 1
108010085238 Actins Proteins 0.000 description 1
241000894006 Bacteria Species 0.000 description 1
241000269333 Caudata Species 0.000 description 1
241001364569 Cofana spectra Species 0.000 description 1
239000012625 DNA intercalator Substances 0.000 description 1
238000001712 DNA sequencing Methods 0.000 description 1
241000588724 Escherichia coli Species 0.000 description 1
241000206602 Eukaryota Species 0.000 description 1
241000282412 Homo Species 0.000 description 1
108020005196 Mitochondrial DNA Proteins 0.000 description 1
206010062575 Muscle contracture Diseases 0.000 description 1
KEQFTVQCIQJIQW-UHFFFAOYSA-N N-Phenyl-2-naphthylamine Chemical compound C=1C=C2C=CC=CC2=CC=1NC1=CC=CC=C1 KEQFTVQCIQJIQW-UHFFFAOYSA-N 0.000 description 1
MKYBYDHXWVHEJW-UHFFFAOYSA-N N-[1-oxo-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propan-2-yl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(C(C)NC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 MKYBYDHXWVHEJW-UHFFFAOYSA-N 0.000 description 1
GMZVRMREEHBGGF-UHFFFAOYSA-N Piracetam Chemical compound NC(=O)CN1CCCC1=O GMZVRMREEHBGGF-UHFFFAOYSA-N 0.000 description 1
102000001218 Rec A Recombinases Human genes 0.000 description 1
108010055016 Rec A Recombinases Proteins 0.000 description 1
101150104425 T4 gene Proteins 0.000 description 1
239000013504 Triton X-100 Substances 0.000 description 1
229920004890 Triton X-100 Polymers 0.000 description 1
240000008866 Ziziphus nummularia Species 0.000 description 1
238000010521 absorption reaction Methods 0.000 description 1
150000007513 acids Chemical class 0.000 description 1
238000000137 annealing Methods 0.000 description 1
239000000427 antigen Substances 0.000 description 1
102000036639 antigens Human genes 0.000 description 1
108091007433 antigens Proteins 0.000 description 1
125000003118 aryl group Chemical group 0.000 description 1
239000011324 bead Substances 0.000 description 1
239000012148 binding buffer Substances 0.000 description 1
229960002685 biotin Drugs 0.000 description 1
235000020958 biotin Nutrition 0.000 description 1
239000011616 biotin Substances 0.000 description 1
239000008280 blood Substances 0.000 description 1
210000004369 blood Anatomy 0.000 description 1
238000009933 burial Methods 0.000 description 1
238000001444 catalytic combustion detection Methods 0.000 description 1
239000003086 colorant Substances 0.000 description 1
208000006111 contracture Diseases 0.000 description 1
238000005034 decoration Methods 0.000 description 1
230000003247 decreasing effect Effects 0.000 description 1
238000010586 diagram Methods 0.000 description 1
239000000539 dimer Substances 0.000 description 1
238000010291 electrical method Methods 0.000 description 1
230000005611 electricity Effects 0.000 description 1
230000008030 elimination Effects 0.000 description 1
238000003379 elimination reaction Methods 0.000 description 1
ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 1
229960005542 ethidium bromide Drugs 0.000 description 1
238000000684 flow cytometry Methods 0.000 description 1
238000001502 gel electrophoresis Methods 0.000 description 1
230000005484 gravity Effects 0.000 description 1
238000010438 heat treatment Methods 0.000 description 1
239000012771 household material Substances 0.000 description 1
150000002431 hydrogen Chemical class 0.000 description 1
125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
238000007901 in situ hybridization Methods 0.000 description 1
238000011065 in-situ storage Methods 0.000 description 1
230000000977 initiatory effect Effects 0.000 description 1
230000003993 interaction Effects 0.000 description 1
238000009830 intercalation Methods 0.000 description 1
239000003456 ion exchange resin Substances 0.000 description 1
229920003303 ion-exchange polymer Polymers 0.000 description 1
XDROKJSWHURZGO-UHFFFAOYSA-N isopsoralen Natural products C1=C2OC=CC2=C2OC(=O)C=CC2=C1 XDROKJSWHURZGO-UHFFFAOYSA-N 0.000 description 1
238000001499 laser induced fluorescence spectroscopy Methods 0.000 description 1
239000006249 magnetic particle Substances 0.000 description 1
238000004519 manufacturing process Methods 0.000 description 1
150000002739 metals Chemical class 0.000 description 1
238000000386 microscopy Methods 0.000 description 1
238000010369 molecular cloning Methods 0.000 description 1
QCOXCILKVHKOGO-UHFFFAOYSA-N n-(2-nitramidoethyl)nitramide Chemical compound [O-][N+](=O)NCCN[N+]([O-])=O QCOXCILKVHKOGO-UHFFFAOYSA-N 0.000 description 1
230000007935 neutral effect Effects 0.000 description 1
229910052759 nickel Inorganic materials 0.000 description 1
238000001821 nucleic acid purification Methods 0.000 description 1
229940038384 octadecane Drugs 0.000 description 1
UYDLBVPAAFVANX-UHFFFAOYSA-N octylphenoxy polyethoxyethanol Chemical group CC(C)(C)CC(C)(C)C1=CC=C(OCCOCCOCCOCCO)C=C1 UYDLBVPAAFVANX-UHFFFAOYSA-N 0.000 description 1
229960004526 piracetam Drugs 0.000 description 1
239000000047 product Substances 0.000 description 1
125000006239 protecting group Chemical group 0.000 description 1
MLMVLVJMKDPYBM-UHFFFAOYSA-N pseudoisopsoralene Natural products C1=C2C=COC2=C2OC(=O)C=CC2=C1 MLMVLVJMKDPYBM-UHFFFAOYSA-N 0.000 description 1
230000002285 radioactive effect Effects 0.000 description 1
238000009790 rate-determining step (RDS) Methods 0.000 description 1
239000011535 reaction buffer Substances 0.000 description 1
238000012216 screening Methods 0.000 description 1
KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
229950005143 sitosterol Drugs 0.000 description 1
241000894007 species Species 0.000 description 1
238000009987 spinning Methods 0.000 description 1
238000003860 storage Methods 0.000 description 1
239000004094 surface-active agent Substances 0.000 description 1
230000008685 targeting Effects 0.000 description 1
238000010998 test method Methods 0.000 description 1
238000012876 topography Methods 0.000 description 1
239000011534 wash buffer Substances 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6816—Hybridisation assays characterised by the detection means

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Microbiology (AREA)
Immunology (AREA)
Physics & Mathematics (AREA)
Molecular Biology (AREA)
Biotechnology (AREA)
Biophysics (AREA)
Analytical Chemistry (AREA)
Biochemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
General Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

TW087102841A 1997-02-27 1998-03-12 Assaying nucleotides in solution using pna probes TW389791B (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US80790197A	1997-02-27	1997-02-27
US08/870,370 US6060242A (en)	1997-02-27	1997-06-06	PNA diagnostic methods

Publications (1)

Publication Number	Publication Date
TW389791B true TW389791B (en)	2000-05-11

Family

ID=27123055

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
TW087102841A TW389791B (en)	1997-02-27	1998-03-12	Assaying nucleotides in solution using pna probes

Country Status (13)

Country	Link
EP (1)	EP0975800B1 (2)
JP (1)	JP4110223B2 (2)
AT (1)	ATE241018T1 (2)
AU (1)	AU736701B2 (2)
CA (1)	CA2282704C (2)
CY (1)	CY2406B1 (2)
DE (1)	DE69814848T2 (2)
DK (1)	DK0975800T3 (2)
ES (1)	ES2202821T3 (2)
IN (1)	IN188176B (2)
PT (1)	PT975800E (2)
TW (1)	TW389791B (2)
WO (1)	WO1998038334A1 (2)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP4034351B2 (ja)	1996-04-25	2008-01-16	バイオアレイソリューションズエルエルシー	粒子近接表面の光制御した動電学的アッセンブリ
US6251591B1 (en) *	1997-02-27	2001-06-26	Lorne Park Research, Inc.	Quantitative method for detecting nucleotide concentration
US6046004A (en) *	1997-02-27	2000-04-04	Lorne Park Research, Inc.	Solution hybridization of nucleic acids with antisense probes having modified backbones
WO2000034521A1 (en) *	1998-12-08	2000-06-15	Boston Probes, Inc.	Methods, kits and compositions for the identification of nucleic acids electrostatically bound to matrices
DE69938400T2 (de) *	1998-12-08	2009-04-23	Boston Probes, Inc., Bedford	Verfahren, Kits und Zusammensetzungen zur Identifizierung von elektrostatisch an Matrizen gebundenen Nukleinsäuren
US6656692B2 (en) *	1999-12-21	2003-12-02	Ingeneus Corporation	Parallel or antiparallel, homologous or complementary binding of nucleic acids or analogues thereof to form duplex, triplex or quadruplex complexes
US6537755B1 (en) *	1999-03-25	2003-03-25	Radoje T. Drmanac	Solution-based methods and materials for sequence analysis by hybridization
US6265170B1 (en) *	2000-01-24	2001-07-24	Ingeneus Corporation	Homogenous assay of duplex of triplex hybridization by means of multiple measurements under varied conditions
US7220541B2 (en) *	2000-01-24	2007-05-22	Ingeneus, Inc.	Homogeneous assay of biopolymer binding by means of multiple measurements under varied conditions
US9709559B2 (en)	2000-06-21	2017-07-18	Bioarray Solutions, Ltd.	Multianalyte molecular analysis using application-specific random particle arrays
EP1392853B1 (en)	2000-08-30	2006-04-26	Avi Biopharma, Inc.	Method for analysis of oligonucleotide analogs
US7262063B2 (en)	2001-06-21	2007-08-28	Bio Array Solutions, Ltd.	Directed assembly of functional heterostructures
EP1463825B1 (en)	2001-10-15	2017-12-06	BioArray Solutions Ltd.	Multiplexed analysis of polymorphic loci by concurrent interrogation and enzyme-mediated detection
US7810380B2 (en)	2003-03-25	2010-10-12	Tearlab Research, Inc.	Systems and methods for collecting tear film and measuring tear film osmolarity
US7041453B2 (en)	2002-08-22	2006-05-09	Bioarray Solutions Ltd.	Molecular constructs and methods of use for detection of biochemical reactions
US7526114B2 (en)	2002-11-15	2009-04-28	Bioarray Solutions Ltd.	Analysis, secure access to, and transmission of array images
CA2539824C (en)	2003-09-22	2015-02-03	Xinwen Wang	Surface immobilized polyelectrolyte with multiple functional groups capable of covalently bonding to biomolecules
EP1678495A4 (en) *	2003-10-20	2007-06-27	Univ California	TRANSDUCTION SYSTEMS IN THE NANOMASSIC STATION FOR DETECTING MOLECULAR INTERACTIONS
CA2899287A1 (en)	2003-10-28	2005-05-12	Bioarray Solutions Ltd.	Optimization of gene expression analysis using immobilized capture probes
US7848889B2 (en)	2004-08-02	2010-12-07	Bioarray Solutions, Ltd.	Automated analysis of multiplexed probe-target interaction patterns: pattern matching and allele identification
ES2546743B1 (es)	2014-03-28	2016-07-07	Institut D'investigació Biomèdica De Bellvitge (Idibell)	Marcadores mitocondriales de enfermedades neurodegenerativas
CN106716116B (zh)	2014-09-23	2021-04-27	蒂尔实验室研究有限公司	用于微流体泪液收集和感兴趣的分析物的横向流动分析的集成的系统和方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0232967B1 (en) *	1986-01-10	1993-04-28	Amoco Corporation	Competitive homogeneous assay
EP0533906A4 (en) *	1991-04-11	1994-09-28	Baxter Diagnostics Inc	Detection of dna/rna by fluorescence polarization
US5539082A (en) *	1993-04-26	1996-07-23	Nielsen; Peter E.	Peptide nucleic acids
DE4216949C2 (de) *	1992-05-22	1997-07-24	Christoph Prof Dr Dr Cremer	Nichtenzymatisches Verfahren zur In-situ-Hybridisierung bei spezifischen Proben
JPH11512617A (ja) *	1995-10-06	1999-11-02	パーセプテイブ・バイオシステムズ・インコーポレイテツド	ペプチド核酸プローブを用いるハイブリダイゼーション分析のための方法、装置及びキット

1998
- 1998-02-23 JP JP53746398A patent/JP4110223B2/ja not_active Expired - Fee Related
- 1998-02-23 PT PT98910911T patent/PT975800E/pt unknown
- 1998-02-23 ES ES98910911T patent/ES2202821T3/es not_active Expired - Lifetime
- 1998-02-23 EP EP98910911A patent/EP0975800B1/en not_active Expired - Lifetime
- 1998-02-23 CA CA002282704A patent/CA2282704C/en not_active Expired - Fee Related
- 1998-02-23 WO PCT/IB1998/000521 patent/WO1998038334A1/en not_active Ceased
- 1998-02-23 DE DE69814848T patent/DE69814848T2/de not_active Expired - Fee Related
- 1998-02-23 AT AT98910911T patent/ATE241018T1/de not_active IP Right Cessation
- 1998-02-23 DK DK98910911T patent/DK0975800T3/da active
- 1998-02-23 AU AU65135/98A patent/AU736701B2/en not_active Ceased
- 1998-02-26 IN IN486DE1998 patent/IN188176B/en unknown
- 1998-03-12 TW TW087102841A patent/TW389791B/zh not_active IP Right Cessation
2004
- 2004-02-13 CY CY0400009A patent/CY2406B1/xx unknown

Also Published As

Publication number	Publication date
DE69814848D1 (de)	2003-06-26
PT975800E (pt)	2003-10-31
AU6513598A (en)	1998-09-18
CA2282704A1 (en)	1998-09-03
CY2406B1 (en)	2004-09-10
ATE241018T1 (de)	2003-06-15
CA2282704C (en)	2007-11-13
AU736701B2 (en)	2001-08-02
ES2202821T3 (es)	2004-04-01
JP4110223B2 (ja)	2008-07-02
EP0975800A1 (en)	2000-02-02
IN188176B (2)	2002-08-31
WO1998038334A1 (en)	1998-09-03
DK0975800T3 (da)	2003-09-22
JP2001514497A (ja)	2001-09-11
DE69814848T2 (de)	2004-05-06
EP0975800B1 (en)	2003-05-21

Legal Events

Date	Code	Title	Description
2000-10-11	GD4A	Issue of patent certificate for granted invention patent
2010-02-21	MM4A	Annulment or lapse of patent due to non-payment of fees

Publication	Publication Date	Title
TW389791B (en)	2000-05-11	Assaying nucleotides in solution using pna probes
US6060242A (en)	2000-05-09	PNA diagnostic methods
TWI235765B (en)	2005-07-11	A method for detecting at least one single-stranded or double-stranded nucleotide sequence in a liquid medium
JP2662556B2 (ja)	1997-10-15	ハイブリダイゼーシヨンによる細菌ならびに他の生命体の核酸検出用のオリゴヌクレオチドプローブおよび方法
EP0760011B1 (en)	2002-10-23	Method for testing for mutations in dna from a patient sample
US6046004A (en)	2000-04-04	Solution hybridization of nucleic acids with antisense probes having modified backbones
US6020124A (en)	2000-02-01	Detection of soluble gene sequences in biological fluids
US20030027159A1 (en)	2003-02-06	Multiparametric fluorescence in situ hybridization
US7052844B2 (en)	2006-05-30	Purification of DS-DNA using heteropolymeric capture probes and a triplex, quadruplex or homologous duplex binding mechanism
KR100617427B1 (ko)	2006-08-30	다양한 조건하의 다중 측정에 의한 생중합체 결합의 균일분석 방법
AU758466B2 (en)	2003-03-20	Multiparametric fluorescence in situ hybridization
Pettersson et al.	1985	Nucleic acid hybridization—an alternative tool in diagnostic microbiology
US7049070B2 (en)	2006-05-23	Materials and methods for detection and characterization of nucleic acid sequence variability
CN103298951B (zh)	2015-06-24	变异型dna的检测方法
JPWO2005001091A1 (ja)	2006-08-10	核酸の変異及び多型の検出用プローブセット、それを固相化したｄｎａアレイ、並びにそれらを用いた変異及び多型の検出方法
Hilborne et al.	1991	Diagnostic applications of recombinant nucleic acid technology: basic techniques
CN104774927B (zh)	2017-05-10	一种检测Leber病线粒体T14502C试剂盒
KR20220166264A (ko)	2022-12-16	마이코박테로이데스·압세수스·컴플렉스에 속하는 항산균의 erm(41) 유전자의 1염기 변이를 판별하는 방법, 그 방법에 사용하는 프라이머 세트 및 프로브
Amano et al.	2005	Quantitative Microarray‐Based DNA‐DNA Hybridization Assay for Measuring Genetic Distances among Bacterial Species and Its Application to the Identification of Family Enterobacteriaceae
Sharma et al.	2006	DNA based diagnostics.
Pappas	1994	Nucleic Acid Probe Assays
CN104774926A (zh)	2015-07-15	检测Leber病线粒体T3394C试剂盒